Related Experiment Video
Updated: Jun 30, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Stem cells for heart cell therapies
Donghui Jing1, Abhirath Parikh, John M Canty
1Department of Chemical and Biological Engineering, State University of New York at Buffalo, Buffalo, New York 14260, USA.
Insights
Stem cell therapy shows promise for repairing heart damage after myocardial infarction. Further research is needed to overcome challenges for clinical application in heart failure treatment.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Biology
Background:
- Myocardial infarction (MI) leads to heart failure, a major cause of death.
- Limited regenerative capacity of cardiac tissue and donor organ scarcity hinder heart transplantation.
- Stem cells offer potential for myocardial repair due to their regenerative and differentiation capabilities.
Purpose of the Study:
- To review recent studies on the cardiogenic potential of stem cells for treating MI-induced heart failure.
- To evaluate the progress and remaining challenges in using stem cells for cardiac tissue engineering.
Main Methods:
- Review of scientific literature on stem cell differentiation into cardiomyocytes.
- Analysis of studies investigating adult progenitor cells and embryonic stem cells for cardiac repair.
- Assessment of current advancements in stem cell-based cardiac tissue engineering.
Main Results:
- Stem cells, including adult progenitor and embryonic stem cells, demonstrate cardiogenic potential.
- Significant progress has been made in engineering cardiac tissues using stem cells.
- Key challenges persist in translating these technologies to clinical settings.
Conclusions:
- Stem cell-based therapies hold promise for treating heart failure following myocardial infarction.
- Further research and development are crucial to address existing hurdles for clinical translation.
- Stem cells represent a potential renewable source for repairing damaged myocardium.
Abstract:
Myocardial infarction-induced heart failure is a prevailing cause of death in the United States and most developed countries. The cardiac tissue has extremely limited regenerative potential, and heart transplantation for reconstituting the function of damaged heart is severely hindered mainly due to the scarcity of donor organs. To that end, stem cells with their extensive proliferative capacity and their ability to differentiate toward functional cardiomyocytes may serve as a renewable cellular source for repairing the damaged myocardium. Here, we review recent studies regarding the cardiogenic potential of adult progenitor cells and embryonic stem cells. Although large strides have been made toward the engineering of cardiac tissues using stem cells, important issues remain to be addressed to enable the translation of such technologies to the clinical setting.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
iPS Cell Differentiation
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Induced Pluripotent Stem Cells

